tirzepatide and semaglutide therapeutic modality What Are the Side Effects of vs. Semaglutide? Semaglutide vs. Tirzepatide for Weight

This trial, which compared tirzepatide treatment to insulin glargine 100 U ml 1 treatment in people with T2D at increased cardiovascular risk, suggested no significant difference in the incidence of major cardiovascular events

This comparison covers both the brand-name and molecule-level evidence

Each trial included at least two treatment arms/groups: one group received tirzepatide either as monotherapy or in combination with other drugs, and the other group was given a placebo or another active comparator, either alone or in combination with other drugs

The overall peak across the treatment course occurs around weeks 4 to 8, coinciding with the dose escalation phase